Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Louisville
With
James Graham Brown Cancer Center
Novartis Pharmaceuticals
The purpose of this research study is to evaluate a new blood test as a way to follow the effect of Zometa in treating bone metastases. The blood test will look for a protein, called TRAP, which is released into the blood stream by the breakdown of bone. This study will compare the TRAP blood test with other blood tests for bone destruction.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
invasive lung cancer (small cell or non-small cell lung cancer)
osteolytic bone metastasis determined by clinical exam, bone scan/XR